WASHINGTON, D.C. — An advisory board for the Food and Drug Administration (FDA) voted 13-10 to authorize the use of Merck's COVID-19 anti-viral pill. The company is seeking an emergency use ...
The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...
NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...
Pfizer said Tuesday morning that final trial studies still show its experimental COVID-19 pill significantly reduced the risk of hospitalization or death linked to the virus by 89%. The company also ...
WASHINGTON — An experimental COVID-19 pill has shown promising results in a preliminary study, the companies developing the drug said Saturday. In a press release, drugmakers Merck and Ridgeback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback